Experts to discuss latest advancements in neurological disorders at Neurorehabilitation Symposium

Scientists and engineers from around the globe will gather in August to share new information regarding neurorehabilitation advances for people with neurological movement disorders, including spinal cord and brain injures.

The 2010 North American Neurorehabilitation Symposium is scheduled for Aug. 27-28 at Shepherd Center, an Atlanta-based facility for medical treatment, research and rehabilitation for people with brain and/or spinal cord injuries, multiple sclerosis and other neuromuscular diseases. Shepherd is co-hosting the symposium with Hocoma, a Swiss medical technology company that specializes in robotic rehabilitation therapy for neurological movement disorders. Its products include Lokomat-, Armeo- and Erigo-.

Topics will include motor learning and motor control, robotic technology in rehabilitation and motivating patients with virtual environments, as well as research in spinal cord injury, stroke, traumatic brain injury, cerebral palsy and other pathologies.

The conference is expected to bring together scientists and engineers from highly recognized institutions worldwide and clinical users of innovative therapeutic methods and technologies.

The event is intended to offer clinicians and scientists a valuable platform to discuss trends, share expertise, exchange ideas and gain knowledge to assess and use new technologies and therapy concepts in their daily practice.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Specific redox protein identified as a critical regulator of ferroptosis